-
1
المؤلفون: Eleonora De Maio, Gabrielle Selmes, Slimane Zerdoud, Eva Jouve, R. Aziza, Jean-Louis Lacaze, Ciprian Chira, F. Izar, Florence Dalenc, C. Massabeau, Mony Ung, Anne Pradines
المصدر: Breast, Vol 59, Iss, Pp 144-156 (2021)
The Breast : Official Journal of the European Society of Mastologyمصطلحات موضوعية: Oncology, Review, NA, not applicable, Circulating Tumor DNA, law.invention, Circulating tumor cell, Randomized controlled trial, law, Epidemiology, HER2, human epidermal growth factor receptor 2, ctDNA, circulating tumor DNA, RC254-282, Curative intent, Incidence (epidemiology), Incidence, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, General Medicine, CTCs, circulating tumor cells, Neoplastic Cells, Circulating, Observational Studies as Topic, CT scan, Computed Tomography scan, 18F-FDG-PET/CT, Positron Emission Tomography/Computed Tomography with 18fluorodeoxyglucose, Female, CTCs, Cohort study, medicine.medical_specialty, 18F-FES, 16α-[18F]-Fluoro- 17β-estradiol, Breast Neoplasms, MRI, Magnetic Resonance Imaging, OMD, oligometastatic disease, OS, overall survival, MBC, Metastatic Breast Cancer, Breast cancer, Internal medicine, RFS, relapse-free survival, Biomarkers, Tumor, medicine, Humans, OMBC, oligometastatic breast cancer, Oligometastatic breast cancer, Biology, business.industry, HR, hormone receptor, Definition, medicine.disease, WB-MRI, Whole-body MRI, MicroRNAs, NED, No Evidence of Disease, SBR grade, Scarf-Bloom-Richardson grade, SBRT, Stereotactic Body Radiotherapy, Surgery, Observational study, Observatory, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b69d7d75860baca5664d0f6f4d7d4a88Test
http://www.sciencedirect.com/science/article/pii/S0960977621004069Test -
2
المؤلفون: Quchang Ouyang, Xin Yi, Xiaohong Yang, Jianxiang Gao, Zheyu Hu, Xuming Hu, Can Tian, Lianpeng Chang, Xuefeng Xia, Yu Tang, Qianjin Liao, Mengjia Xiao, Qiongzhi He, Liping Liu, Hui Wu, Jing Li, Jun Lu, Ning Xie, Huawu Xiao, Min Cao, Zhengrong Shui
المصدر: EBioMedicine
EBioMedicine, Vol 32, Iss, Pp 111-118 (2018)مصطلحات موضوعية: 0301 basic medicine, Oncology, MBC, metastatic breast cancer, ER, estrogen receptor, Receptor, ErbB-2, Gene mutation pattern, Estrogen receptor, lcsh:Medicine, Drug resistance, SNV, Single nucleotide variants, Gene mutation, medicine.disease_cause, Circulating Tumor DNA, SEER, Surveillance Epidemiology and End Results, AUC, area under the curve, Phosphatidylinositol 3-Kinases, 0302 clinical medicine, HER2, human epidermal growth factor receptor 2, ctDNA, circulating tumor DNA, Indels, insertions and deletions, Neoplasm Metastasis, skin and connective tissue diseases, Triple-negative breast cancer, TNBC, triple negative breast cancer, Mutation, lcsh:R5-920, Mediator Complex, BRCA1 Protein, Progression-free survival, General Medicine, Middle Aged, Metastatic breast cancer, PFS, progression-free survival, Drug Resistance, Multiple, Gene Expression Regulation, Neoplastic, GX, gemcitabine+capecitabine, 030220 oncology & carcinogenesis, Disease Progression, Female, lcsh:Medicine (General), Circulating tumor DNA (ctDNA), WES, whole exome sequencing, IHC, immunohistochemistry, Research Paper, Adult, medicine.medical_specialty, Class I Phosphatidylinositol 3-Kinases, Breast Neoplasms, General Biochemistry, Genetics and Molecular Biology, Disease-Free Survival, 03 medical and health sciences, Internal medicine, medicine, Biomarkers, Tumor, Humans, neoplasms, AI, aromatase inhibitor, Aged, HR/HER2 subtype, TMB, Tumor mutation burden, business.industry, lcsh:R, Cancer, HR, hormone receptor, PR, progesterone receptor, cfDNA, cell-free DNA, medicine.disease, HR, hazard ratio, ROC, receiver operating characteristic, CI, confidence interval, 030104 developmental biology, Drug Resistance, Neoplasm, gDNA, genomic DNA, Tumor Suppressor Protein p53, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09ba2a916d616434f8644bf3d44cb54dTest
http://europepmc.org/articles/PMC6020712Test